APT Medical Inc.'s (SHSE:688617) Share Price Could Signal Some Risk
Apt Medical Inc. (688617.SH) subsidiary obtained a medical instruments registration certificate.
apt medical inc. (688617.SH) released an announcement that on November 21, 2024, its wholly-owned subsidiary hunan...
apt medical inc. (688617.SH): It is expected that consumables related to atrial fibrillation will gradually increase in volume in the second half of 2025.
Gelonghui, November 12th | apt medical inc. (688617.SH) stated on the interactive platform that the company expects the consumption of atrial fibrillation-related supplies to gradually increase in the second half of 2025; the company's management holds a cautious and optimistic attitude towards the increase in atrial fibrillation supplies.
We Think That There Are Issues Underlying APT Medical's (SHSE:688617) Earnings
Third Quarter Report 2024
apt medical inc. (688617.SH): net income for the first three quarters was 0.528 billion yuan, a year-on-year increase of 30.97%.
Gelonghui reported on October 25th that apt medical inc. (688617.SH) released its third-quarter report, with revenue of 1.52 billion yuan in the first three quarters, a year-on-year increase of 25.63%, net income of 0.528 billion yuan, a year-on-year increase of 30.97%, non-GAAP net income of 0.508 billion yuan, a year-on-year increase of 41.08%, and basic earnings per share of 5.44 yuan.
Is APT Medical Inc.'s (SHSE:688617) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Apt Medical Inc. (688617.SH): Obtained medical instrument registration certificate for embolization spring coil.
Apt Medical Inc. (688617.SH) announced that its wholly-owned subsidiary, Hunan Apt Medical Instruments Co., Ltd., has obtained a medical instrument registration certificate for the product named Embolization Spring Coil. The acquisition of the aforementioned medical instrument registration certificate is conducive to enriching the company's product range, expanding its product layout in the peripheral field, continuously meeting diverse clinical demands, and further enhancing the company's core competitiveness.
Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention
SSE Science and Technology Innovation Board 50 Index sample adjustment: apt medical inc. (688617.SH), Company 9 (689009.SH) included in the adjustment.
On August 30th, according to the index rules, the Shanghai Stock Exchange and China Securities Index Co., Ltd. decided to adjust the sample of the SSE Science and Technology Innovation Board 50 Index, which will take effect after the market closes on September 13, 2024.
APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Southwest Securities: How to view the investment opportunities and challenges of high-value consumables in the post-medicine group purchase era?
In the context of centralized procurement, most areas in the high-value consumables field are currently highly competitive and have limited growth potential. Therefore, the tracks with low penetration rates and low localization rates have long-term growth potential.
Is APT Medical (SHSE:688617) Using Too Much Debt?
APT Medical Gets Registration Certificate for Catheter
Apt Medical Inc. (688617.SH): Obtained the Medical Instrument Registration Certificate for Disposable Magnetic Positioning Ring Marker Catheter.
Apt Medical Inc. (688617.SH) announced on August 7th that the company has obtained a medical instrument registration certificate for a disposable magnetic positioning ring marker catheter. The acquisition of this registration certificate for medical instruments helps enrich the variety of products offered by the company, expanding the company's product layout in the field of cardiac electrophysiology, continuously meeting diverse clinical needs, and further enhancing the company's core competitiveness.
Risks Still Elevated At These Prices As APT Medical Inc. (SHSE:688617) Shares Dive 27%
Apt Medical Inc. (688617.SH) plans to distribute 20 yuan per 10 shares and convert 4.5 shares on July 26th, 2023.
Apt Medical Inc. (688617.SH) announced the company's plan to distribute a cash dividend of RMB 1.0 (tax included) per 10 shares to all shareholders for the year 2023.
APT Medical Inc.'s (SHSE:688617) Stock Has Fared Decently: Is the Market Following Strong Financials?
No Data
No Data